About
Expression System for Recombinant Protein Production
Areas of Focus
Categories
Non-Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
93
By Phase
PHASE1: 2
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06746688Lead Sponsor
A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2 Expressing Metastatic Breast Cancer.
PHASE1Recruiting
27 participants
Started: Jun 3, 2025 · Completed: Mar 31, 2026
NCT02647489Collaborator
Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted
PHASE1Completed
66 participants
Started: May 31, 2016 · Completed: Nov 10, 2017
Locations (1)
Headquarters
Hørsholm, Denmark
Map
Loading map...